Skip to main content
Year archive

DAEWOONG PHARMA — 2021 filings

All 46 regulatory filings released by DAEWOONG PHARMA (069620) in 2021, sourced directly from the official regulator.

46 Filings
2021 Period
2021 filings (46)
Filing Released Lang
투자판단관련주요경영사항
Regulatory Filings
2021-12-31 Korean
투자판단관련주요경영사항
Regulatory Filings
2021-12-30 Korean
투자판단관련주요경영사항
Legal Proceedings Report
2021-12-08 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2021-11-17 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-15 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2021-11-01 Korean
영업(잠정)실적(공정공시)
Earnings Release Q3 2021
2021-10-27 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2021-10-15 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-08-17 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-08-17 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-17 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2021-08-09 Korean
영업(잠정)실적(공정공시)
Earnings Release Q2 2021
2021-07-29 Korean
투자설명서
Capital/Financing Update
2021-07-22 Korean
증권발행실적보고서
Capital/Financing Update
2021-07-22 Korean
[발행조건확정]증권신고서(채무증권)
Capital/Financing Update
2021-07-21 Korean
[발행조건확정]증권신고서(채무증권)
Capital/Financing Update
2021-07-16 Korean
증권신고서(채무증권)
Capital/Financing Update
2021-07-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2021-07-02 Korean
투자판단관련주요경영사항(펙수프라잔(Fexuprazan) 기술이전(Licensing Out) 계약 체결)
M&A Activity
2021-06-08 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2021-05-18 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-17 Korean
영업(잠정)실적(공정공시)
Earnings Release Q1 2021
2021-05-06 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-26 Korean
타법인주식및출자증권취득결정
M&A Activity
2021-03-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-03-26 Korean
투자판단관련주요경영사항
Legal Proceedings Report
2021-03-24 Korean
[기재정정]단일판매ㆍ공급계약체결
Capital/Financing Update
2021-03-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-03-23 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification
2021-03-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-03-22 Korean
자기주식처분결과보고서
Transaction in Own Shares
2021-03-22 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update
2021-03-18 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2021-03-18 Korean
사업보고서 (2020.12)
Audit Report / Information FY 2020
2021-03-18 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-11 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2021-03-11 Korean
주주총회소집결의
AGM Information
2021-03-11 Korean
주주총회집중일개최사유신고
AGM Information
2021-03-11 Korean
주주총회소집공고
AGM Information
2021-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-11 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information
2021-02-22 Korean
영업(잠정)실적(공정공시)
Earnings Release Q4 2020
2021-02-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2020
2021-02-15 Korean
투자판단관련주요경영사항(코로나치료제 DWJ1248의 COVID-19 예방 목적 임상3상 시험계획 승인)
Regulatory Filings
2021-01-25 Korean